PM Modi visited the COVID-19 vaccine namely Bharat Biotech,Zydus biotech and Serum Institute facilities located in Hyderabad, Ahmedabad and Pune respectively. To review the progress of COVID-19 vaccine development.
Prime Minister Narendra Modi visited Bharat Biotech’s facility in Hyderabad on Saturday. He reviewed the current development work in the coronavirus vaccine. He tweeted about his visits to the Bharat Biotech Facility. He also interacted with Bharat Biotech chairman and managing director Krishna Ella, scientists and senior management.
“At the Bharat Biotech Facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine,congratulated scientists for their progress in trials so far.Their team is closely working with ICMR to facilitate speedy progress”his tweet read.
Bharat Biotech’s COVAXIN is India’s indigenous COVID-19 vaccine. It has been developed in collaboration with the ICMR(Indian Council of Medical Research) if the National Institute of Virology.The vaccine is being developed and manufactured in Bharat Biotech’s Bio Safety Level 3 high containment facility. Its phase one and two human clinical trials that took place across India since July 2020 have been approved by the DCGI.The third phase clinical trials with 26 thousand participants around 25 centres across india are under process.
. PM Narendra Modi visited Serum Institute in Pune,he also interacted with their head Adar Poonawala.The SII has partnered with global pharma giant AstraZeneca and the Oxford University for the vaccine.
PM Modi also Visited the Zydus Biotech Park in Ahmedabad near Ahmedabad to know more about the indigenous DNA based vaccine.He appreciated the team behind the development in his tweet.
“Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey,” his tweet read.
He wore a PPE kit suit during all his visits to these facilities and reviewed and briefed the vaccine work done by these companies in detail.
This might interest you: India based Hetero to produce over 100 million Sputnik V vaccine in India